Relmada Therapeutics, Inc.
RLMDNasdaqCIK 1553643HealthcareFiscal year ends Dec 31
Reports and events: 237 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-0808:00 ET | 8-K | 8.01 Other events | 0001213900-26-097851 |
| 2026-08-0616:40 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-086190 |
| 2026-08-0616:14 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-086151 |
| 2026-07-2808:35 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-082007 |
| 2026-05-2816:59 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-062184 |
| 2026-05-1217:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-055164 |
| 2026-05-1216:05 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-055059 |
| 2026-04-1716:30 ET | DEF 14A | Proxy statementPeriod 2026-05-27 | 0001213900-26-045192 |
| 2026-03-2016:52 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-032403 |
| 2026-03-1916:25 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-031862 |
| 2026-03-0907:11 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-024918 |
| 2025-12-1507:50 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-121461 |
| 2025-11-1316:58 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-110088 |
| 2025-11-1316:07 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-109983 |
| 2025-11-0521:25 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-106398 |
| 2025-11-0407:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-105593 |
| 2025-09-1707:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-088360 |
| 2025-09-1608:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-087926 |
| 2025-09-1008:46 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-086389 |
| 2025-09-0207:30 ET | 8-K | 7.01 Regulation FD disclosure | 0001213900-25-082910 |
| 2025-08-0717:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-073130 |
| 2025-08-0716:06 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-073073 |
| 2025-07-2316:30 ET | 8-K | 3.01 Delisting notice | 0001213900-25-066995 |
| 2025-07-1016:30 ET | 8-K | 1.02 Termination of a material agreement | 0001213900-25-062803 |
| 2025-06-1819:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-055334 |
| 2025-05-2716:15 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-047805 |
| 2025-05-1216:06 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-042025 |
| 2025-05-1216:05 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-25-042024 |
| 2025-04-2813:18 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-035941 |
| 2025-04-1116:15 ET | DEF 14A | Proxy statementPeriod 2025-05-23 | 0001213900-25-031088 |
| 2025-03-2716:42 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001013762-25-003432 |
| 2025-03-2716:40 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001013762-25-003426 |
| 2025-03-2617:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001013762-25-002786 |
| 2025-02-0606:38 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-010711 |
| 2025-01-2707:30 ET | 8-K | 3.01 Delisting notice | 0001213900-25-006727 |
| 2025-01-0617:29 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-001249 |
| 2024-12-0907:49 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-106646 |
| 2024-12-0407:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-105245 |
| 2024-11-0716:05 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001213900-24-095398 |
| 2024-08-0716:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001213900-24-066111 |
| 2024-05-3016:05 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-24-047968 |
| 2024-05-0816:06 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001213900-24-040856 |
| 2024-04-0916:10 ET | DEF 14A | Proxy statementPeriod 2024-05-24 | 0001213900-24-031600 |
| 2024-03-1916:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-024022 |
| 2024-03-1916:05 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001213900-24-024013 |
| 2024-01-1116:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-24-003000 |
| 2024-01-0408:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-000999 |
| 2024-01-0317:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-24-000858 |
| 2023-11-0816:05 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001213900-23-084737 |
| 2023-11-0816:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-084735 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. Listed shows no prices and gives no investment advice.